Michel Magloire Yop Kite

Michel Magloire Yop Kite

Auto-generated profile, based on publicly available information

Michel Magloire Yop Kite

Center for Expertise and Research in Applied Biology (CEREBA), Douala, Cameroon; Department of Biochemistry, Faculty of Sciences, The University of Douala, Cameroon

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 January 2026 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
MKMichel M. Yop Kite
Michel M. Yop Kite
BKBrice L. Koloko
Brice L. Koloko
SBSandrine S. Beack Bayengue
Sandrine S. Beack Bayengue
ELEMBOLO ENYEGUE ELISEE LIBERT
EMBOLO ENYEGUE ELISEE LIBERT
ATAlphonse G. Tandja
Alphonse G. Tandja
Loick Pradel Kojom FokoLoick Pradel Kojom Foko
Loick Pradel Kojom Foko
This systematic review and meta-analysis (SRMA) was designed to determine the prevalence, patterns, and determinants of major transfusion-transmitted infections (TTIs), to address this gap, and to propose solutions to the current identified blood transfusion-related challenges in Cameroon. Pooled estimates of TTI-related infection rates, that is, human immunodeficiency virus - HIV, hepatitis B/C viruses - HBV/HCV, and Treponema pallidum, were computed using random effects models. Subgroup and sensitivity analyses were performed, and methodological bias analysis was assessed using the Joanna Briggs Institute tools. A total of 36 studies, spanning 72 datasets for ∼105,000 blood donations, were included. Most of them were conducted in family donors attending health facilities of three towns, viz. Yaoundé (51.4%), Douala (25.7%), and Bamenda (8.6%). The pooled proportion of TTIs was 15.4% (95% CI: 12.7-18.2%), and was significantly modulated by several variables (e.g., testing strategy, area). These pathogens could occur as coinfections at a pooled proportion of 1.5%, with HBV + HCV being the most prevalent (3.4%). Across studies, the risk for HIV and T. pallidum infection was consistently higher in family donors. Several challenges, including diagnostic inconsistencies (even within the same assay) and a lack of evidence data on determinants, residual risk, and the extent of occult hepatitis B infection, were identified, primarily due to the paucity and underreporting of data in certain regions. The review outlines a significant burden of HIV, HBV, HCV, and T. pallidum in blood donors. High-quality studies are needed to fill these gaps to inform public health policymakers and assist the development and implementation of better blood safety strategies and services.

3 July 2025 in VirusDisease
Verified
Journal Article
Closed access
PDF file
GHGildas Ingrid Deutou Hogoue
Gildas Ingrid Deutou Hogoue
CSChristiane Medi Sike
Christiane Medi Sike
KEKikie Josiane Essola
Kikie Josiane Essola
ZTZaïna Polyclaire Ngansop Tchapdjouo
Zaïna Polyclaire Ngansop Tchapdjouo
STSteve Armand Nzogang Tchonet
Steve Armand Nzogang Tchonet
MMMartin Luther Koanga Mogtomo
Martin Luther Koanga Mogtomo

24 October 2026 in Medical Mycology
Verified
Journal Article
Closed access
MNMegane D Malieuze Nanfah
Megane D Malieuze Nanfah
MKMichel M Yop Kite
Michel M Yop Kite
SESolange Meyin A. Ebong
Solange Meyin A. Ebong
EOEliane V Assokom Okoubalimba
Eliane V Assokom Okoubalimba
SNSéverin Tchameni Nguemezi
Séverin Tchameni Nguemezi
Loick Pradel Kojom FokoLoick Pradel Kojom Foko
Loick Pradel Kojom Foko
Vulvovaginal candidiasis is a common fungal infection, mainly due to Candida species, affecting two-thirds of women globally at least once in their lifetime. Here, we conducted a systematic review and meta-analysis (PROSPERO ID: CRD420261368975) of the epidemiology, aetiology, and drug resistance profiles of vulvovaginal Candida infections and vulvovaginal candidiasis (VVC) in Cameroon. Databases were queried to identify all eligible papers. Data were extracted, and the methodological quality of studies was assessed. Random-effect models were used to estimate pooled proportions of primary outcomes. Thirty-four studies were included. The pooled proportions of vulvovaginal Candida infections and VVC were 33.3% (Confidence interval at 95% (95% CI) 25.5%–41.6%, P < .0001) and 31.6% (95% CI 26.9%–36.4%, P < .0001), respectively. Candida albicans (23.3%, 95% CI 17.9%–29.1%, P < .0001) was the most frequently isolated causative species, followed by Nakaseomyces glabratus (formerly C. glabrata) (2.3%, 95% CI 0.9%–4.2%, P < .0001) and Pichia kudriavzevii (formerly C. krusei) (1.3%, 95% CI 0.5%–2.5%, P < .0001). Pregnancy status, diagnostic methods, and human immunodeficiency virus infection influenced the proportions of these species. Two primary azoles were least effective against C. albicans, with the following resistance levels: fluconazole (51.1%, 95% CI 21.2%–80.7%, P < .0001) and itraconazole (50.5%, 95% CI 41.3%–100%, P < .0001). Evidence of drug profiles for non-albicans species is limited. The findings highlight the substantial burden of VVC, the predominance of C. albicans, and high azole resistance in Cameroon. They underscore the need for standardised diagnostic approaches, broader epidemiological surveillance, and evidence-based preventive strategies.

23 April 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
MNMegane Dorcasse Malieuze Nanfah
Megane Dorcasse Malieuze Nanfah
MKMichel Magloire Yop Kite
Michel Magloire Yop Kite
SESolange Meyin A Ebong
Solange Meyin A Ebong
EOEliane Vanessa Assokom Okoubalimba
Eliane Vanessa Assokom Okoubalimba
SNSéverin Tchameni Nguemezi
Séverin Tchameni Nguemezi
Loick Pradel Kojom FokoLoick Pradel Kojom Foko
Loick Pradel Kojom Foko
Background: Vulvovaginal candidiasis is a common fungal infection, mainly due to Candida albicans, affecting two-thirds of women at least once in their lifetime. Here, we conducted a systematic review and meta-analysis (PROSPERO ID: CRD420261368975) of the epidemiology, aetiology, and drug resistance profiles of VVC in Cameroon.Methods: Databases were queried to identify all eligible papers. Data were extracted, and the quality bias of studies was assessed. Random effect models were used to estimate pooled proportions of primary outcomes.Results: Thirty-four studies were included. The pooled proportion of VVC was 33.3% (95%CI 25.5 – 41.6%, p < 0.0001). Candida albicans (23.3%, 95%CI 17.9 – 29.1%, p < 0.0001) was the most frequently isolated causative species, followed by C. glabrata (2.3%, 95%CI 0.9 – 4.2%, p < 0.0001) and C. krusei (1.3%, 95%CI 0.5 – 2.5%, p < 0.0001). Pregnancy status, diagnostic methods, and human immunodeficiency virus infection influenced the proportions of these species. Three drugs were least effective against C. albicans, with the following resistance levels: fluconazole (51.1%, 95%CI 21.2 – 80.7%, p < 0.0001) and itraconazole (50.5%, 95%CI 41.3 – 100%, p < 0.0001). Evidence of drug profiles for non-albicans species is limited.Conclusions: The findings have spotlighted several urgent challenges (e.g., the lack of studies in two regions of Cameroon, or the need for diagnostic standardisation), and will help to propose effective control strategies and guidelines.

3 September 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
MNMegane Dorcasse Malieuze Nanfah
Megane Dorcasse Malieuze Nanfah
SESolange Meyin A Ebong
Solange Meyin A Ebong
MKMichel Magloire Yop Kite
Michel Magloire Yop Kite
SNSéverin Tchameni Nguemezi
Séverin Tchameni Nguemezi
MMMartin Luther Koanga Mogtomo
Martin Luther Koanga Mogtomo
Loick Pradel Kojom FokoLoick Pradel Kojom Foko
Loick Pradel Kojom Foko
Background: Oral candidiasis is a common opportunistic disease. This systematic review and meta-analysis (PROSPERO ID: CRD420261369027) aimed to assess the burden and drug resistance patterns of oral candidiasis in Cameroon. Methods: Six databases were queried to identify relevant studies as per PRISMA guidelines. Random-effects models were used to pool proportions of primary outcomes (e.g., oral candidiasis). Sources of heterogeneity were searched via subgroup, leave-one-out, meta-regression and publication bias analysesResults: n total, 28 studies were eligible for the SRMA. The pooled proportion of oral candidiasis was 24.2% (95%CI 14.7 – 35.2%, I2 = 99.1%, p = 0), despite high between-study heterogeneity, with higher rates in HIV/AIDS individuals (31.7%, 95%CI 17.0 – 48.6%, I2 = 99.2%, p < 0.0001) and those from the Southwest region (32.4%, 95%CI 15.6 – 52.0%, I2 = 94.5%, p < 0.0001). Candida albicans was the leading causative species (27.0%, 95%CI 8.9 – 50.4%, I2 = 99.4%, p = 0), while the 12 other identified species occurred at proportions < 2%. The C. albicans resistance rates were found against fluconazole (37.5%, 95%CI 23.6 - 81.3%, I2 = 96.7%, p < 0.0001), nystatin (26.6%, 95%CI 20.3 - 89.2%, I2 = 98.3%, p < 0.0001), and 5-flucytosine (25.1%, 95%CI 21.4 - 98.9%, I2 = 98%, p < 0.0001), in spite of the high heterogeneity found for these estimates. There were no consistent patterns of drug resistance among non-albicans species. Missing links, e.g., diagnostic inconsistencies, lack of clinical impact studies, and lack of genetic and treatment efficacy studies, were identified.Conclusions: The study provides crucial epidemiological evidence to inform decision-making and to guide priorities for future research in Cameroon.

31 December 2025 in Health Sciences Review
Verified
Journal Article
Open access
Loick Pradel Kojom FokoLoick Pradel Kojom Foko
Loick Pradel Kojom Foko
MKMichel M. Yop Kite
Michel M. Yop Kite
MNMegane D. Malieuze Nanfah
Megane D. Malieuze Nanfah
VNVerónica M. Binam Nkot
Verónica M. Binam Nkot
SBSandrine S. Beack Bayengue
Sandrine S. Beack Bayengue
MMMartin L. Koanga Mogtomo
Martin L. Koanga Mogtomo